This company is no longer active
Resumen de acción SELECT B
Selectimmune Pharma AB (publ), a pharmaceutical company, develops drugs for the treatment of acute and chronic infections.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
+ 1 riesgos adicionales
Competidores de Selectimmune Pharma AB (publ)
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | kr2.38 |
| 52 Week High | kr5.58 |
| 52 Week Low | kr1.20 |
| Beta | 1.21 |
| 1 Month Change | -0.42% |
| 3 Month Change | 5.78% |
| 1 Year Change | -48.71% |
| 3 Year Change | -83.92% |
| 5 Year Change | n/a |
| Change since IPO | -76.55% |
Noticias y actualizaciones recientes
Rentabilidad de los accionistas
| SELECT B | SE Pharmaceuticals | Mercado SE | |
|---|---|---|---|
| 7D | 3.9% | 0.1% | 0.4% |
| 1Y | -48.7% | 48.9% | 11.4% |
Rentabilidad vs. Industria: SELECT B underperformed the Swedish Pharmaceuticals industry which returned -7.9% over the past year.
Rentabilidad vs. Mercado: SELECT B underperformed the Swedish Market which returned -2.3% over the past year.
Volatilidad de los precios
| SELECT B volatility | |
|---|---|
| SELECT B Average Weekly Movement | 22.8% |
| Pharmaceuticals Industry Average Movement | 7.2% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in SE Market | 13.5% |
| 10% least volatile stocks in SE Market | 3.6% |
Precio estable de las acciones: SELECT B's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: SELECT B's weekly volatility has increased from 18% to 23% over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2017 | 2 | Gabriela Godaly | www.selectimmune.com |
Resumen de fundamentos de Selectimmune Pharma AB (publ)
| Estadísticas fundamentales de SELECT B | |
|---|---|
| Capitalización bursátil | kr41.55m |
| Beneficios(TTM) | -kr8.65m |
| Ingresos (TTM) | n/a |
0.0x
Ratio precio-ventas (PS)-4.8x
Ratio precio-beneficio (PE)¿Está SELECT B sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de SELECT B | |
|---|---|
| Ingresos | kr0 |
| Coste de los ingresos | kr0 |
| Beneficio bruto | kr0 |
| Otros gastos | kr8.65m |
| Beneficios | -kr8.65m |
Últimos beneficios comunicados
Mar 31, 2023
Próxima fecha de beneficios
Aug 29, 2023
| Beneficios por acción (BPA) | -0.50 |
| Margen bruto | 0.00% |
| Margen de beneficio neto | 0.00% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado SELECT B a largo plazo?
Ver rendimiento histórico y comparativa